Monday, April 4, 2016

BRIEF-Cytrx presents aldoxorubicin phase 3 clinical trial data

* Cytrx global pivotal phase 3 clinical trial with aldoxorubicin achieves 191 target events triggering statistical data analysis











Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)